News

Exciting Milestone: Our First Scientific Paper Published in Biomedical Optics Express!

We are thrilled to announce the publication of our first scientific technical paper, “Minimally-invasive common-path OCT system for neurosurgery applications” in Biomedical Optics Express. This marks a significant milestone for our team at Clee Medical as we advance the frontiers of neurosurgical imaging technology.

Our research presents a groundbreaking optical coherence tomography (OCT) system tailored specifically for neurosurgery. This minimally invasive, forward-viewing, common-path...

Real-Time Precision: Overcoming the Limitations of MRI in Neurosurgery

In stereotactic neurosurgery, procedures such as neuromodulation, biopsies, stereoelectroencephalography (sEEG), and lesioning demand sub-millimeter precision to achieve their intended therapeutic effect. However, current imaging methods—most commonly MRI (Magnetic Resonance Imaging)—pose significant limitations that impact surgical accuracy and outcomes. At Clee Medical, we have developed an intraoperative imaging system designed to overcome these challenges, enabling real-time neural targeting with micron-level precision.

The Problem: MRI and...

Clee Medical, a neuro technology start up focused on transforming the landscape of brain treatments. Officially incorporated in October 2024, Clee Medical is proud to spin out of the Wyss Center in Geneva, Switzerland. With a vision to revolutionize neurointerventional precision and outcomes, Clee Medical is at the forefront of developing cutting-edge, minimally invasive neurotechnologies that empower clinicians with real-time imaging, AI-driven navigation, and machine learning insights for true confidence in neural targeting. Clee Medical’s...